Abstract
An imbalance between oxidative stress and antioxidative capacity has been proposed to play an important role in the development and progression of chronic obstructive pulmonary disease. We carried out a study to assess the systemic oxidant-antioxidant status in patients with chronic obstructive pulmonary disease (COPD) and relate it to the severity of disease. We measured a wide range of parameters of oxidant-antioxidant balance in leukocytes, plasma and red cells of 82 patients with COPD and 22 healthy non-smoking controls (HNC). Lung function was measured by spirometry. Staging of COPD was done as per the recommended guidelines. Red cell antioxidative enzyme activities were altered, with glutathione peroxidase (GSH-Px) having lower, superoxide dismutase (SOD) having greater and catalase having similar activity in patients as compared to HNC. In plasma, ferric reducing antioxidant power (FRAP) and total protein sulfhydryls were lower and GSH-Px, lipid peroxides measured as MDA-TBA products, and protein carbonyls were higher in the patients as compared to HNC. Plasma total nitrates and nitrites (NO x ) were similar in the two groups. Superoxide anion (O2•−) release from leukocytes upon stimulation with N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMLP) and total blood glutathione were also higher in patients as compared to HNC. Plasma FRAP had a positive whereas total blood glutathione had a significant negative correlation with the severity of airways obstruction (FEV1% predicted). Further, comparisons between clinical stages of severity of COPD revealed significant differences in plasma FRAP and total blood glutathione. Our observations suggest there is a systemic oxidant-antioxidant imbalance in the patients with COPD.
Similar content being viewed by others
Abbreviations
- COPD:
-
chronic obstructive pulmonary disease
- HNC:
-
healthy non-smoking controls
- GSH-Px:
-
glutathione peroxidase
- ROS:
-
reactive oxygen species
- SOD:
-
superoxide dismutase
- NO x :
-
total nitrates and nitrites
- AM:
-
alveolar macrophages
- BAL:
-
bronchoalveolar lavage
- (O2•−):
-
superoxide radical
- NO•:
-
nitric oxide
- FRAP:
-
ferric reducing antioxidant power
- KRP-D:
-
krebs-ringer phosphate buffer with dextrose
- fMLP:
-
N-formyl-L-methionyl-L-leucyl-L-phenylalanine
- MDA-TBA products:
-
malondialdehyde-thiobarbituric acid products
- NADPH:
-
nicotinamide adenine dinucleotide phosphate, reduced form
- INT:
-
2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium chloride
- DTNB:
-
5,5′-dithiobis(2-nitrobenzoic acid)
- Hb:
-
hemoglobin
References
American Thoracic Society. 1995. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. ATS Statement (supplement). Am. J. Respir. Crit. Care Med. 152:S77–S121.
Martin, T. R., G. Raghu, R. J. Maunder, and S. C. Springmeyer. 1985. The effects of chronic bronchitis and chronic airflow obstruction on lung populations recovered by bronchoalveolar lavage. Am. Rev. Respir. Dis. 132:254–260.
Hubbard, R. C., F. Ogushi, G. A. Fels, A. M. Cantin, M. Courtney, and R. G. Crystal. 1987. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha-1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase. J. Clin. Invest. 80:1289–1295.
Rahman, I., D. Morrison, K. Donaldson, and W. MacNee. 1996. Systemic oxidative stress in asthma, COPD and smokers. Am. J. Respir. Crit. Care. Med. 159:1055–1060.
Pryor, W. A., and K. Stone. 1993. Oxidants in cigarette smoke: Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann. N.Y.Acad. Sci. 686:12–28.
Eiserich, J. P., C. E. Cross, and A. vanderVliet. 1997. Nitrogen oxides are important contributors to cigarette smoke induced ascorbate oxidation. In: Vitamin C in health and disease, L. Packer and J. Fuchs, eds. Dekker, New York, pp. 399–412.
Schaberg, T., H. Haller, M. Rau, D. Kaiser, M. Fassebender, and H. Lode. 1992. Superoxide anion release induced by platelet-activating factor is increased in human alveolar macrophages from smokers. Eur. Resp. J. 5:387–393.
Morrison, D., I. Rahman, S. Lannan, and W. MacNee. 1999. Epithelial permeability, inflammation, and oxidant stress in the airspaces of smokers. Am. J. Respir. Crit. Care Med. 159:473–479.
Fishman, A. 1985. The pulmonary circulation. In: Handbook of Physiology, Section 3: The Respiratory System, A. Fishman, ed. American Physiological Society. Bathesda, MD, pp. 93–165.
MacNee, W., W. Wiggs, A. S. Belzberg, and J. C. Hogg. 1989. Regional pulmonary transit times in man. J. Appl. Physiol. 66:844–850.
Richards, G. A., A. J. Therson, A. Carel, V. D. Merwe, and R. Anderson. 1989. Spirometric abnormalities in young smokers correlate with increased chemiluminiscence responses of activated blood phagocytes. Am. Rev. Resp. Dis. 139:181–187.
Pinamonti, S., M. Muzzoli, M. C. Chicca, A. Papi, F. Ravenna, L. M. Fabbri, and A. Ciaccia. 1996. Xanthine oxidase activity in bronchoalveolar lavage fluid from patients with chronic obstructive pulmonary disease. Free. Rad. Biol. Med. 21:147–155.
Postma, D. S., T. E. J. Renkema, J. A. Noordhock, H. Faber, H. J. Sluiter, and H. Kauffman. 1988. Association between nonspecific bronchial hyperreactivity and superoxide anion production by polymorphonuclear leukocytes in chronic airflow obstruction. Am. Rev. Resp. Dis. 137:57–61.
Ludwig, P. W., and J. R. Hoidal. 1982. Alterations in leukocyte oxidative metabolism in cigarette smokers. Am. Rev. Resp. Dis. 126:977–980.
Toth, K. M., D. P. Clifford, E. M. Berger, C. W. White, and J. E. Repine. 1984. Intact human erythrocyte prevents hydrogen peroxide mediated damage to isolated perfused rat lungs and cultured bovine pulmonary artery endothelial cells. J. Clin. Invest. 74:292–295.
Van Asbeck, B. S., J. Hoidal, G. M. Vercelloti, B. A. Schwartz, C. F. Moldow, and H. S. Jacob. 1985. Protection against lethal hyperoxia by tracheal insufflation of erythrocytes: role of red cell glutathione. Science 227:756–759.
Agar, N. S., S. N. H. Sadradeh, P. E. Hallaway, and J. W. Eaton. 1986. Erythrocyte catalase. A somatic oxidant defense. J. Clin. Invest. 77:319–321.
Heffner, J. E., and J. E. Repine. 1991. Antioxidants and the lung. In: The lung: Scientific foundations, R. G. Crystal and W. B. West, eds. Raven Press, New York, pp. 1811–1820.
McCusker, K., and J. Hoidal. 1990. Selective increase of antioxidant enzyme activity in the alveolar macrophages from cigarette smokers and smoke–exposed hamsters. Am. Rev. Resp. Dis. 141:678–682.
Kondo, T., S. Tagami, A. Yoshioka, M. Nishimura, and Y. Kawakami. 1994. Current smoking of elderly men reduces antioxidants in alveolar macrophages. Am. J. Respir. Crit. Care Med. 149:178–182.
Morrow, J. D., B. Frei, and A. W. Longwire. 1995. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. N. Engl. J. Med. 332:1198–1203.
Pratico, D., S. Basili, M. Vieri, C. Cordova, F. Violi, and G. A. FitzGerald. 1998. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2α-III, an index of oxidant stress. Am. J. Respir. Crit .Care Med. 158:1709–1714.
Pauwels, R. A., S. A. Buist, P. M. A. Calverley, C. R. Jenkins, and S. S. Hurd. 2001. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am. J. Respir. Crit. Care Med. 163:1256–1276.
Chhabra, S. K., S. Rajpal, and R. Gupta. 2001. Patterns of smoking in Delhi: Comparison of respiratory morbidity among Bidi and Cigarette smokers. Ind. J. Chest. Dis. Allied. Sci. 43:19–26.
Lehmeyer, J. E., R. Synderman, and R. B. Johnson. 1979. Stimulation of neutrophil oxidative metabolism by chemotactic peptides: Influence of calcium ion concentration and cytochalasin B and comparison with stimulation by phorbol myristate acetate. Blood 54:35–45.
Little, C., R. Olinescu, K. G. Reid, and P. J. O'Brien. 1970. Properties and regulation of glutathione peroxidase. J. Biol. Chem. 245:3632–3636.
Benzie, I. F. F., and J. J. Strain. 1996. The Ferric Reducing Ability of Plasma (FRAP) as a measure of “Antioxidant Power”: The FRAP Assay. Anal. Chem. 239:70–76.
Tracey, W. R., J. Tse, and G. Carter. 1995. Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J. Pharm. Exptl. Ther. 272:1011–1015.
Dousset, J., M. Trouilh, and M. Foglietti. 1983. Plasma malonaldehyde levels during myocardial infarction. Clin. Chim. Acta. 129:319–322.
Hu, M.-L., C. J. Dillard, and A. Tappel. 1988. In vivo effects of aurothioglucose and sodium thioglucose on rat tissue sulfhydryls and plasma sulfhydryl reactivity. Agents. Actions 25:132–137.
Levine, R. L., D. Garlard, C. N. Oliver, A. Amici, I. Climent, A. G. Lenz, B. W. Ahn, S. Shaltiel, and E. Stadman. 1990. Determination of carbonyl content in oxidatively modified proteins. In: Methods in Enzymology. Vol. 186, N. Packer and A. N. Glazer, eds. Raven Press, New York, pp. 464–472.
Aebi, H. 1974. Catalase. In: Methods in Enzymatic Analysis Vol 2, H. U. Bergmeyer, ed. Academic Press, New York, pp. 673–678.
McCord, J. M. and I. Fridovich. 1969. Superoxide dismutase. An enzymatic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244:6049–6055.
Griffith, O. W. 1980. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106:207–212.
Montuschi, P., S. A. Kharitonov, and P. J. Barnes. 2001. Exhaled carbon monoxide and nitric oxide in COPD. Chest 120:496–501.
Dekhuijzen, P. N. R., K. K. H. Aben, I. Dekker, L. P. H. J. Aarts, P. L. M. L. Wielders, C. L. C. Van Herwaarden, and A. Bast. 1996. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 154:813–816.
Petrone, W. F., D. K. English, K. Wong, and J. M. McCord. 1980. Free radicals and inflammation: Superoxide-dependent activation of a neutrophil chemotactic factor in plasma. Proc. Natl. Acad. Sci. USA. 77:1159–1163.
Lehr, H.-A., E. Kress, M. D. Menger, H. P. Friedl, C. Hubner, K. E. Arfors, and K. Messmer. 1993. Cigarette smoke elicits leukocyte adhesion to endothelium in hamsters:Inhibition by CuZn-SOD. Free. Rad. Biol.Med. 14:573–581.
Balint, B., L. E. Donnelly, T. Hanazawa, S. A. Kharitonov, and P. J. Barnes. 2001. Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke. Thorax 56:456–461.
Rutgers, S. R, T. W. V. Mark, W. Coers, H. Moshage, W. Timens, H. F. Kauffman, G. H. Koeter, and D. S. Postma. 1999. Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease. Thorax. 54:576–580.
Blum, J., and I. Fridovich. 1985. Inactivation of glutathione peroxidase by superoxide radical. Arch. Biochem. Biophys. 249:500–508.
Comhair, S. A. A., M. J. Thomassen, and S. C. Erzurum. 2000. Differential induction of extracellular glutathione peroxidase and nitric oxide synthase 2 in the airways of healthy individuals exposed to 100% O2 or cigarette smoke. Am. J. Respir. Cell. Mol. Biol. 23:350–354.
Rahman, I., C. A. D. Smith, M. F. Lawson, D. J. Harrison, and W. MacNee. 1996. Induction of gamma-glutamylcysteine synthetase by cigarette smoke is associated with AP-1 in human alveolar epithelial cells. FEBS. Lett. 396:21–25.
Lynch, R. E. and I. Fridovich. 1978. Permeation of the erythrocyte stroma by superoxide radical. J. Biol .Chem. 253: 4697–4699.
Cross, C. E., C. A. O'Neill, A. Z. Reznick, M. L. Hu, L. Marcocci, L. Packer, and B. Frei. 1993. Cigarette smoke oxidation of human plasma constituents. Ann. N.Y. Acad. Sci. USA 686:72–90.
Reznick, A. Z., C. E. Cross, M. L. Hu, Y. J. Suzuki, S. Khwaja, A. Safadi, P. A. Motchnik, L. Packer, and B. Halliwell. 1982. Modification of plasma proteins by cigarette smoke as measured by protein carbonyls formation. Biochem. J. 286:607–611.
Frei, B., T. M. Forte, B. N. Ames, and C. E. Cross. 1991. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Biochem. J. 277:133–138.
Linden, M., J. B. Rasmussen, L. Pitulainen, A. Tunek, M. Larson, H. Tegner, P. Venge, L. A. Laitinen, and R. Brattsand. 1993. Airway inflammation in smokers and non–obstructive and obstructive chronic bronchitis. Am Rev Respir Dis. 48:1226–1232.
Rahman, I., E. Swarska, M. Henry, J. Stolk, and W. MacNee. 2000. Is there any relationship between plasma antioxidant capacity and lung function in smokers and patients with chronic obstructive pulmonary disease? Thorax. 55:189–193.
Ghiselli, A., M. Serafini, F. Natella, and C.Scaccini. 2000. Total antioxidant capacity to assess redox status: Critical view and experimental data. Free Radio Biol. Med. 29:1106–1114.
Schafer, F. Q. and G. R. Buettner. 2001. Redox environment of the cells as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radio Biol Med. 30:1191–1212.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nadeem, A., Raj, H.G. & Chhabra, S.K. Increased Oxidative Stress and Altered Levels of Antioxidants in Chronic Obstructive Pulmonary Disease. Inflammation 29, 23–32 (2005). https://doi.org/10.1007/s10753-006-8965-3
Issue Date:
DOI: https://doi.org/10.1007/s10753-006-8965-3